Interview Highlights from the SNMMI 2023 Conference


Catch up on recent interviews with Jeremie Calais, M.D. MSc, Krishna Patel, M.D., Phillip Kuo, M.D. Ph.D, and more faculty from the Society for Nuclear Medicine and Molecular Imaging (SNMMI) 2023 conference.

Whether it was strategies to address the workforce pipeline in nuclear medicine, emerging insights on positron emission tomography (PET) in the management of prostate cancer and new research on the imaging of clear cell renal cell carcinoma, we learned quite a bit during on-site interviews at the Society of Nuclear Imaging and Molecular Imaging (SNMMI) 2023 conference in Chicago. Review the slideshow below to check out some of our on-site interviews from the conference.

Related Videos
Emerging Innovations in Molecular Imaging
Ultra-High Resolution Brain PET: A ‘Quantum Leap’ for Neuroradiology
Emerging PET Radiotracer May Improve Detection of Coronary Artery Disease in Obese Patients
Can SPECT/CT Guidance Facilitate Personalized Dosing for Patients with Prostate Cancer?
New Research Shows Viability of PET Imaging Agent for Clear Cell Renal Cell Carcinoma
A Closer Look at Urinary Activity and PET Radiopharmaceuticals for Prostate Cancer Imaging
Expediting the Management of Incidental Pulmonary Emboli on CT
Radiology Challenges with Breast Cancer Screening in Women with Breast Implants
Related Content
© 2023 MJH Life Sciences

All rights reserved.